Gemmer Asset Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-230
| Closed | -$10K | – | 242 |
|
|
2022
Q1 | $10K | Buy |
230
+24
| +12% | +$1.04K | ﹤0.01% | 693 |
|
|
2021
Q4 | $9K | Sell |
206
-140
| -40% | -$5.88K | ﹤0.01% | 777 |
|
|
2021
Q3 | $15K | Sell |
346
-100
| -22% | -$4.42K | ﹤0.01% | 553 |
|
|
2021
Q2 | $19K | Buy |
446
+40
| +10% | +$1.68K | ﹤0.01% | 545 |
|
|
2021
Q1 | $16K | Hold |
406
| – | – | ﹤0.01% | 578 |
|
|
2020
Q4 | $15K | Sell |
406
-307
| -43% | -$11.1K | ﹤0.01% | 542 |
|
|
2020
Q3 | $27K | Hold |
713
| – | – | 0.01% | 317 |
|
|
2020
Q2 | $25K | Hold |
713
| – | – | 0.01% | 319 |
|
|
2020
Q1 | $23K | Sell |
713
-7
| -1% | -$273 | 0.01% | 299 |
|
|
2019
Q4 | $33K | Hold |
720
| – | – | 0.01% | 265 |
|
|
2019
Q3 | $29K | Buy |
720
+8
| +1% | +$339 | 0.01% | 284 |
|
|
2019
Q2 | $31K | Sell |
712
-200
| -22% | -$7.69K | 0.01% | 266 |
|
|
2019
Q1 | $35K | Buy |
912
+200
| +28% | +$7.64K | 0.01% | 255 |
|
|
2018
Q4 | $25K | Hold |
712
| – | – | 0.01% | 281 |
|
|
2018
Q3 | $27K | Hold |
712
| – | – | 0.01% | 300 |
|
|
2018
Q2 | $23K | Sell |
712
-3,200
| -82% | -$96.5K | 0.01% | 344 |
|
|
2018
Q1 | $107K | Hold |
3,912
| – | – | 0.04% | 114 |
|
|
2017
Q4 | $97K | Buy |
3,912
+307
| +9% | +$8.47K | 0.03% | 120 |
|
|
2017
Q3 | $105K | Hold |
3,605
| – | – | 0.04% | 109 |
|
|
2017
Q2 | $100K | Hold |
3,605
| – | – | 0.04% | 108 |
|
|
2017
Q1 | $90K | Sell |
3,605
-1,000
| -22% | -$24.3K | 0.04% | 113 |
|
|
2016
Q4 | $100K | Sell |
4,605
-386
| -8% | -$8.42K | 0.05% | 98 |
|
|
2016
Q3 | $119K | Buy |
4,991
+119
| +2% | +$2.84K | 0.06% | 88 |
|
|
2016
Q2 | $114K | Sell |
4,872
-1,733
| -26% | -$37.5K | 0.06% | 85 |
|
|
2016
Q1 | $124K | Sell |
6,605
-1,000
| -13% | -$17.6K | 0.07% | 94 |
|
|
2015
Q4 | $140K | Sell |
7,605
-2,000
| -21% | -$35.8K | 0.08% | 85 |
|
|
2015
Q3 | $158K | Hold |
9,605
| – | – | 0.1% | 80 |
|
|
2015
Q2 | $170K | Hold |
9,605
| – | – | 0.1% | 75 |
|
|
2015
Q1 | $170K | Sell |
9,605
-2,953
| -24% | -$46.7K | 0.1% | 77 |
|
|
2014
Q4 | $166K | Sell |
12,558
-3,726
| -23% | -$47.6K | 0.11% | 71 |
|
|
2014
Q3 | $192K | Hold |
16,284
| – | – | 0.14% | 72 |
|
|
2014
Q2 | $208K | Hold |
16,284
| – | – | 0.14% | 71 |
|
|
2014
Q1 | $220K | Buy |
+16,284
| New | +$214K | 0.16% | 63 |
|
Other funds holding BSX
BG
Gemmer Asset Management's BSX Position: Q2 2022 in Review
Gemmer Asset Management sold out of Boston Scientific (BSX) in Q2 2022, closing a stake of 230 shares — an estimated $10K sold.
Gemmer Asset Management first reported a position in BSX in Q1 2014 and held it in 33 quarters. The position peaked at $220K in Q1 2014. 880 funds tracked by Wall St. Rank hold BSX as of Q2 2022.
- Gemmer Asset Management reported no remaining Boston Scientific position as of Q2 2022 after selling out during the quarter.
- Gemmer Asset Management sold 230 Boston Scientific shares in Q2 2022, an estimated $10K.
- Gemmer Asset Management first reported a position in Boston Scientific in Q1 2014 and held it in 33 quarters.
- Gemmer Asset Management's Boston Scientific position peaked at $220K in Q1 2014.
- 880 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2022.
Based on Gemmer Asset Management's 13F filing for Q2 2022, filed 22 Jul 2022.